Posted On: 12/13/2016 9:27:55 AM 
  
		  		    Post#  of 110168		    
			
		      
  
	$PRTO -70% on bad news  (15M O/S)  Dec 13, 2016	 Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKD   
http://www.otcmarkets.com/stock/PRTO/news
 	
 
http://www.otcmarkets.com/stock/PRTO/news
 (0)
(0) (0)
(0)
       Sojourner here following God, obeying God, and cleaving to Him. The journey is onward. 
  
    
      
    
   
      			












